National Pension Service grew its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 7.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 225,119 shares of the technology company’s stock after acquiring an additional 15,481 shares during the period. National Pension Service’s holdings in Veeva Systems were worth $50,253,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Jensen Investment Management Inc. increased its holdings in shares of Veeva Systems by 1,924.5% in the third quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock worth $123,100,000 after purchasing an additional 392,802 shares during the period. Alphinity Investment Management Pty Ltd bought a new position in shares of Veeva Systems in the third quarter worth $422,241,000. Principal Financial Group Inc. increased its holdings in shares of Veeva Systems by 11.2% in the third quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock worth $1,146,040,000 after purchasing an additional 388,864 shares during the period. ABN AMRO Bank N.V. bought a new position in shares of Veeva Systems in the third quarter worth $246,625,000. Finally, Robeco Institutional Asset Management B.V. increased its holdings in shares of Veeva Systems by 11.3% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 892,070 shares of the technology company’s stock worth $199,137,000 after purchasing an additional 90,703 shares during the period. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
- Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
- Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
- Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts
Insider Activity
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on VEEV shares. TD Cowen decreased their price target on shares of Veeva Systems from $380.00 to $300.00 and set a “buy” rating on the stock in a report on Thursday, March 5th. Truist Financial reaffirmed a “buy” rating and issued a $262.00 price target (down from $275.00) on shares of Veeva Systems in a report on Thursday, March 5th. Morgan Stanley increased their target price on Veeva Systems from $205.00 to $215.00 and gave the company an “equal weight” rating in a research note on Thursday, March 5th. Canaccord Genuity Group reduced their target price on Veeva Systems from $280.00 to $235.00 and set a “hold” rating on the stock in a research note on Thursday, March 5th. Finally, Oppenheimer reduced their target price on Veeva Systems from $275.00 to $225.00 and set an “outperform” rating on the stock in a research note on Monday, May 18th. Sixteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $276.52.
Get Our Latest Stock Report on Veeva Systems
Veeva Systems Stock Up 5.8%
VEEV opened at $173.97 on Friday. The stock has a market cap of $28.42 billion, a PE ratio of 32.16, a P/E/G ratio of 0.77 and a beta of 0.92. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50. The business’s fifty day simple moving average is $166.38 and its 200 day simple moving average is $199.77.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $835.95 million for the quarter, compared to analysts’ expectations of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The firm’s revenue was up 16.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, equities analysts anticipate that Veeva Systems Inc. will post 6.45 earnings per share for the current year.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
